Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - valaciclovirhydrochlorid - filmovertrukne tabletter - 250 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - valaciclovirhydrochlorid - filmovertrukne tabletter - 500 mg

Evropská unie - dánština - EMA (European Medicines Agency)

novartis europharm limited - valsartan, amlodipine (as amlodipine besilate) - forhøjet blodtryk - agenter, der virker på renin-angiotensinsystemet - behandling af essentiel hypertension. copalia er indiceret hos patienter, hvis blodtryk ikke er tilstrækkeligt kontrolleret på amlodipin eller valsartan monoterapi.

Evropská unie - dánština - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).

Evropská unie - dánština - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformin-hydrochlorid - diabetes mellitus, type 2 - narkotika anvendt i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Evropská unie - dánština - EMA (European Medicines Agency)

pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibakterielle midler til systemisk brug, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. det bør overvejes at officielle vejledning om hensigtsmæssig brug af antibakterielle midler.. hensigtsmæssig brug af antibakterielle midler..

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

alternova a/s - aciclovir - tabletter - 200 mg

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

abbvie a/s - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 100 enheder

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 100 enheder

Dánsko - dánština - Lægemiddelstyrelsen (Danish Medicines Agency)

haemato pharm gmbh - clostridium botulinum, type a toxin - pulver til injektionsvæske, opløsning - 100 enheder